Besides stimulating ERK/STAT3 pathway activation, these cytokines also affect multiple cell populations in the liver, leading, amongst others, to HSC-mediated collagen deposition, thereby contributing to liver fibrosis, which often precedes HBV-related HCC [102]. This evidence concerns the gene STAT3 and hepatocellular carcinoma.